TrialsgrambetaRCTs are beautiful

Louie Fidaxomicin

2011

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

In 629 patients with Clostridium difficile infection, fidaxomicin reduced recurrence at 4 weeks compared with oral vancomycin with similar clinical cure.

Result

Clinical cure and recurrence
Absolute difference
9.9 points

The absolute difference is derived from the event rates.

Also reported: Cure similar (~88 %); fewer with fidaxomicin in non-NAP1 strains.

Original publication
Subtopic
Initial therapy
Design
Double-blind RCT
Relevance
Important: one of several pillars.
Source
Louie TJ, et al. N Engl J Med. 2011;364(5):422-431.doi 10.1056/NEJMoa0910812

Discussion & critique

Established fidaxomicin as the preferred agent for initial and first-recurrence CDI, now reflected in IDSA/SHEA 2021 guidance.

Discussed in podcasts